The case of a rare coexistence of myasthenia gravis (MG) with systemic lupus erythematosus (SLE) is described. MG was diagnosed prior to SLE which developed after thymectomy. The patient was affected by HCV viremia. Therefore, there were therapeutic problems. Metylase treatment was continued for several years and dopamine receptor agonist was effectively administered as adjunctive therapy in SLE.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00296-009-1301-0 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!